1,2-dimyristoylphosphatidylethanolamine has been researched along with amantadine in 1 studies
| Studies (1,2-dimyristoylphosphatidylethanolamine) | Trials (1,2-dimyristoylphosphatidylethanolamine) | Recent Studies (post-2010) (1,2-dimyristoylphosphatidylethanolamine) | Studies (amantadine) | Trials (amantadine) | Recent Studies (post-2010) (amantadine) |
|---|---|---|---|---|---|
| 216 | 0 | 59 | 4,110 | 515 | 753 |
| Protein | Taxonomy | 1,2-dimyristoylphosphatidylethanolamine (IC50) | amantadine (IC50) |
|---|---|---|---|
| Matrix protein 2 | Influenza A virus (A/udorn/1972(H3N2)) | 4.7 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Altamirano, M; Dukes, N; Jemiola-Rzeminska, M; Strzalka, K; Suwalsky, M; Villena, F | 1 |
1 other study(ies) available for 1,2-dimyristoylphosphatidylethanolamine and amantadine
| Article | Year |
|---|---|
Interactions of the antiviral and antiparkinson agent amantadine with lipid membranes and human erythrocytes.
Topics: Amantadine; Antiparkinson Agents; Antiviral Agents; Cell Membrane; Cell Shape; Dimyristoylphosphatidylcholine; Dose-Response Relationship, Drug; Erythrocytes; Humans; Lipid Bilayers; Microscopy, Electron, Scanning; Models, Molecular; Molecular Structure; Phosphatidylethanolamines; Structure-Activity Relationship | 2015 |